Home
RCKT
RCKT News

Latest Rocket Pharmaceuticals Inc. (RCKT) News on January 19, 2025

Rocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

4 days ago

Rocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Business Wire

16 days ago

Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’

TipRanks

19 days ago

Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’

MT Newswires

19 days ago

Rocket Pharmaceuticals' Continued Pipeline Development to Support Long-Term Growth Potential, Wedbush Says

MT Newswires

20 days ago

Wedbush Initiates Rocket Pharmaceuticals at Outperform With $32 Price Target

Rocket Pharmaceuticals, Inc. (RCKT): Is This Gene Therapy Stock a Good Buy Right Now?

Insider Monkey

21 days ago

Rocket Pharmaceuticals, Inc. (RCKT): Is This Gene Therapy Stock a Good Buy Right Now?

Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy'

Investopedia

a month ago

Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy'

MT Newswires

a month ago

Jefferies Initiates Coverage on Rocket Pharmaceuticals With Buy Rating, $29 Price Target

MT Newswires

a month ago

Rocket Pharmaceuticals Prices Upsized $165 Million Stock Offering

Rocket Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Business Wire

a month ago

Rocket Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

MT Newswires

a month ago

Rocket Pharmaceuticals Plans $150 Million Public Offering of Common Shares

Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock

Business Wire

a month ago

Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock

Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference

Business Wire

2 months ago

Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference

Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst

Benzinga

2 months ago

Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst

MT Newswires

2 months ago

Sector Update: Health Care Stocks Lean Lower Premarket Tuesday

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Rocket Pharmaceuticals to Resume Patient Enrollment in RP-L301 Gene Therapy Phase 2 Trial in 2025

Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference

Business Wire

2 months ago

Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference

Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions

Business Wire

2 months ago

Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions

Rocket Pharmaceuticals' Q3 Earnings Beat, Pipeline in Focus

Zacks

2 months ago

Rocket Pharmaceuticals' Q3 Earnings Beat, Pipeline in Focus

Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference

Business Wire

2 months ago

Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference

Associated Press Finance

2 months ago

Rocket Pharmaceuticals: Q3 Earnings Snapshot

Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

Business Wire

2 months ago

Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

Here's Why We're Watching Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Situation

Simply Wall St.

2 months ago

Here's Why We're Watching Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Situation

MT Newswires

3 months ago

Scotiabank Initiates Rocket Pharmaceuticals at Sector Outperform With $50 Price Target

Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease

Business Wire

4 months ago

Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease

Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors

Business Wire

4 months ago

Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors

Rocket Stock Down More Than 30% in Past Six Months: Here's Why

Zacks

4 months ago

Rocket Stock Down More Than 30% in Past Six Months: Here's Why

Rocket Pharmaceuticals (RCKT) Down 10.6% Since Last Earnings Report: Can It Rebound?

Zacks

4 months ago

Rocket Pharmaceuticals (RCKT) Down 10.6% Since Last Earnings Report: Can It Rebound?

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Business Wire

5 months ago

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks

TipRanks

5 months ago

Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks

MT Newswires

5 months ago

Rocket Pharmaceuticals Files Mixed-Shelf Offering

Associated Press Finance

5 months ago

Rocket Pharmaceuticals: Q2 Earnings Snapshot

Should You Maintain Your Conviction in Rocket Pharmaceuticals (RCKT)?

Insider Monkey

6 months ago

Should You Maintain Your Conviction in Rocket Pharmaceuticals (RCKT)?

MT Newswires

7 months ago

Canaccord Genuity Adjusts Price Target on Rocket Pharmaceuticals to $40 From $49, Maintains Buy Rating

FDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease

Zacks

7 months ago

FDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease

MT Newswires

7 months ago

Needham Trims Price Target on Rocket Pharmaceuticals to $52 From $53, Maintains Buy Rating

MT Newswires

7 months ago

Rocket Pharmaceuticals Says FDA Seeks More Information on Kresladi

FDA Rejects Rocket Pharmaceuticals' Gene Therapy For Rare Immune Disorder, Asks For More Data, Stock Slides

Benzinga

7 months ago

FDA Rejects Rocket Pharmaceuticals' Gene Therapy For Rare Immune Disorder, Asks For More Data, Stock Slides

Rocket gene therapy rejected by FDA over manufacturing

BioPharma Dive

7 months ago

Rocket gene therapy rejected by FDA over manufacturing

Rocket Pharmaceuticals Provides Regulatory Update on KRESLADI™ (marnetegragene autotemcel; marne-cel)

Business Wire

7 months ago

Rocket Pharmaceuticals Provides Regulatory Update on KRESLADI™ (marnetegragene autotemcel; marne-cel)

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

7 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

7 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

7 months ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

7 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

7 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

7 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

7 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

7 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

$6.6 Billion Digital X-ray Market, 2024-2029: Development of AI-based Digital X-Ray Systems Present Business Opportunities

GlobeNewswire

7 months ago

$6.6 Billion Digital X-ray Market, 2024-2029: Development of AI-based Digital X-Ray Systems Present Business Opportunities

2 Reasons to Buy Rivian Stock (and 1 Big Reason to Sell)

Motley Fool

7 months ago

2 Reasons to Buy Rivian Stock (and 1 Big Reason to Sell)

DFR Gold Inc. Announces Amendment of WUO Land Option and Insider Loans

CNW Group

7 months ago

DFR Gold Inc. Announces Amendment of WUO Land Option and Insider Loans

Walmart Stock Climbs After Dow Jones Giant Receives Upgrade, Major Price Target Hike

Investor's Business Daily

7 months ago

Walmart Stock Climbs After Dow Jones Giant Receives Upgrade, Major Price Target Hike

EPCOR and HAWSCo Enter Ownership Transfer Agreement

CNW Group

7 months ago

EPCOR and HAWSCo Enter Ownership Transfer Agreement

Video on Demand (VoD) Market Report 2024-2034: Netflix, Amazon, Google and Hulu Dominate

GlobeNewswire

7 months ago

Video on Demand (VoD) Market Report 2024-2034: Netflix, Amazon, Google and Hulu Dominate

Southwest Airlines stock pops on report of Elliott's $2B stake

Yahoo Finance Video

7 months ago

Southwest Airlines stock pops on report of Elliott's $2B stake

Business Wire

7 months ago

Form 8.3 - Virgin Money UK plc

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

7 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

7 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

7 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

7 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

7 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

7 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

7 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

7 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?

Zacks

7 months ago

Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?

Rocket Pharmaceuticals (NASDAQ:RCKT) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

8 months ago

Rocket Pharmaceuticals (NASDAQ:RCKT) Is In A Good Position To Deliver On Growth Plans

EC grants orphan medicinal product status to Rocket’s RP-A601

Pharmaceutical Technology

8 months ago

EC grants orphan medicinal product status to Rocket’s RP-A601

MT Newswires

8 months ago

Rocket Pharmaceuticals' Gene Therapy for Inherited Heart Disease Receives Orphan Drug Designation in Europe

Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy

Business Wire

8 months ago

Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy

MT Newswires

8 months ago

UBS Adjusts Rocket Pharmaceuticals Price Target to $51 From $54, Maintains Buy Rating

MT Newswires

8 months ago

Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise

Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Business Wire

8 months ago

Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil

Zacks

8 months ago

Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil

Associated Press Finance

8 months ago

Rocket Pharmaceuticals: Q1 Earnings Snapshot

Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress

Business Wire

8 months ago

Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals (RCKT) Upgraded to Buy: Here's Why

Zacks

9 months ago

Rocket Pharmaceuticals (RCKT) Upgraded to Buy: Here's Why

Should You Retain Your Conviction in Rocket Pharmaceuticals (RCKT)?

Insider Monkey

9 months ago

Should You Retain Your Conviction in Rocket Pharmaceuticals (RCKT)?

EMA Accepts Rocket (RCKT) Gene Therapy Filing for Fanconi Anemia

Zacks

9 months ago

EMA Accepts Rocket (RCKT) Gene Therapy Filing for Fanconi Anemia

Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia

Business Wire

10 months ago

Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia

Why Is Rocket Pharmaceuticals (RCKT) Down 13.6% Since Last Earnings Report?

Zacks

10 months ago

Why Is Rocket Pharmaceuticals (RCKT) Down 13.6% Since Last Earnings Report?

Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team

Business Wire

10 months ago

Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team

Rocket (RCKT) Registers Narrower-Than-Expected Loss in Q4

Zacks

a year ago

Rocket (RCKT) Registers Narrower-Than-Expected Loss in Q4

Associated Press Finance

a year ago

Rocket Pharmaceuticals: Q4 Earnings Snapshot

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress

Business Wire

a year ago

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress

15 Best Strong Buy Stocks To Invest In

Insider Monkey

a year ago

15 Best Strong Buy Stocks To Invest In

Rocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Business Wire

a year ago

Rocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Artisan Partners Asset Management (NYSE:APAM) Is Paying Out A Larger Dividend Than Last Year

Simply Wall St.

a year ago

Artisan Partners Asset Management (NYSE:APAM) Is Paying Out A Larger Dividend Than Last Year

International Seaways to Announce Fourth Quarter and Full Year 2023 Results on February 29, 2024

Business Wire

a year ago

International Seaways to Announce Fourth Quarter and Full Year 2023 Results on February 29, 2024

First Interstate BancSystem Full Year 2023 Earnings: Revenues Disappoint

Simply Wall St.

a year ago

First Interstate BancSystem Full Year 2023 Earnings: Revenues Disappoint

Thomson Reuters StreetEvents

a year ago

Q4 2023 First Interstate Bancsystem Inc Earnings Call

AIR Communities Announces Quarterly Common Dividend of $0.45 Per Share

Business Wire

a year ago

AIR Communities Announces Quarterly Common Dividend of $0.45 Per Share

M/I Homes Reports Fourth Quarter and Year-End Results

PR Newswire

a year ago

M/I Homes Reports Fourth Quarter and Year-End Results

First Interstate BancSystem (FIBK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

a year ago

First Interstate BancSystem (FIBK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

First Interstate BancSystem Inc (FIBK) Reports Mixed Q4 Earnings Amidst Economic Challenges

GuruFocus.com

a year ago

First Interstate BancSystem Inc (FIBK) Reports Mixed Q4 Earnings Amidst Economic Challenges

IPG Photonics to Announce Fourth Quarter 2023 Financial Results on February 13

GlobeNewswire

a year ago

IPG Photonics to Announce Fourth Quarter 2023 Financial Results on February 13

Hedge Fund Anson Gains 18% as Activist Stock Wins Outpace Crypto Losses

Bloomberg

a year ago

Hedge Fund Anson Gains 18% as Activist Stock Wins Outpace Crypto Losses

Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call

GlobeNewswire

a year ago

Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call

CVB Financial Corp. (NASDAQ:CVBF) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

CVB Financial Corp. (NASDAQ:CVBF) Q4 2023 Earnings Call Transcript

Innovative Industrial Properties (IIPR) Gains As Market Dips: What You Should Know

Zacks

a year ago

Innovative Industrial Properties (IIPR) Gains As Market Dips: What You Should Know

Share on Social Networks: